These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In vivo epigenome editing and transcriptional modulation using CRISPR technology. Lau CH, Suh Y. Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145 [Abstract] [Full Text] [Related]
14. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects. Rahman MM, Tollefsbol TO. Methods; 2021 Mar 15; 187():77-91. PubMed ID: 32315755 [Abstract] [Full Text] [Related]
15. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells. Pham H, Kearns NA, Maehr R. Methods Mol Biol; 2016 Mar 15; 1358():43-57. PubMed ID: 26463376 [Abstract] [Full Text] [Related]
16. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii. Markus BM, Boydston EA, Lourido S. mSphere; 2021 Oct 27; 6(5):e0047421. PubMed ID: 34643425 [Abstract] [Full Text] [Related]
17. CRISPR-based epigenome editing: mechanisms and applications. Fadul SM, Arshad A, Mehmood R. Epigenomics; 2023 Nov 27; 15(21):1137-1155. PubMed ID: 37990877 [Abstract] [Full Text] [Related]